Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Rheumatology
Volume 2014, Article ID 329059, 2 pages
http://dx.doi.org/10.1155/2014/329059
Case Report

Acute Onset Polymyositis after Prolactinoma Extirpation

1Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga 15, Tlalpan, 14000 Mexico City, Mexico
2Medicine Direction, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga 15, Tlalpan, 14000 Mexico City, Mexico

Received 14 August 2014; Accepted 21 October 2014; Published 6 November 2014

Academic Editor: Constantine Saadeh

Copyright © 2014 Juan Jakez-Ocampo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Orbach and Y. Shoenfeld, “Hyperprolactinemia and autoimmune diseases,” Autoimmunity Reviews, vol. 6, no. 8, pp. 537–542, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Buskila, M. Berezin, H. Gur et al., “Autoantibody profile in the sera of women with hyperprolactinemia,” Journal of Autoimmunity, vol. 8, no. 3, pp. 415–424, 1995. View at Publisher · View at Google Scholar · View at Scopus
  3. L. J. Jara, G. Medina, M. A. Saavedra, O. Vera-Lastra, and C. Navarro, “Prolactin and autoimmunity,” Clinical Reviews in Allergy and Immunology, vol. 40, no. 1, pp. 50–59, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Saha, J. Gonzalez, G. Rosenfeld, H. Keiser, and E. Peeva, “Prolactin alters the mechanisms of B cell tolerance induction,” Arthritis and Rheumatism, vol. 60, no. 6, pp. 1743–1752, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Matera, M. Mori, and A. Galetto, “Effect of prolactin on the antigen presenting function of monocyte-derived dendritic cells,” Lupus, vol. 10, pp. 728–734, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Peeva, J. Venkatesh, D. Michael, and B. Diamond, “Prolactin as a modulator of B cell function: implications for SLE,” Biomedicine & Pharmacotherapy, vol. 58, no. 5, pp. 310–319, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Peeva, D. Michael, J. Cleary, J. Rice, X. Chen, and B. Diamond, “Prolactin modulates the naive B cell repertoire,” The Journal of Clinical Investigation, vol. 111, no. 2, pp. 275–283, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. A. M. Jacobi, W. Rohde, H.-D. Volk, T. Dörner, G.-R. Burmester, and F. Hiepe, “Prolactin enhances the in vitro production of IgG in peripheral blood mononuclear cells from patients with systemic lupus erythematosus but not from healthy controls,” Annals of the Rheumatic Diseases, vol. 60, no. 3, pp. 242–247, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Chuang and M. E. Molitch, “Prolactin and autoimmune diseases in humans,” Acta Biomedica, vol. 78, supplement 1, pp. 255–261, 2007. View at Google Scholar · View at Scopus
  10. L. J. Jara, P. Cruz-Cruz, M. A. Saavedra et al., “Bromocriptine during pregnancy in systemic lupus erythematosus: a pilot clinical trial,” Annals of the New York Academy of Sciences, vol. 1110, pp. 297–304, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. R. W. McMurray, D. Weidensaul, S. H. Allen, and S. E. Walker, “Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus,” Journal of Rheumatology, vol. 22, no. 11, pp. 2084–2091, 1995. View at Google Scholar · View at Scopus